AMA
Langer T, Limuti R, Tommasino C, et al. Intravenous fluid therapy for hospitalized and critically ill children: rationale, available drugs and possible side effects. Anestezjologia Intensywna Terapia. 2018:50-59.
APA
Langer, T., Limuti, R., Tommasino, C., Regenmortel, N. V., Duval, E. L., & Caironi, P. et al. (2018). Intravenous fluid therapy for hospitalized and critically ill children: rationale, available drugs and possible side effects. Anestezjologia Intensywna Terapia, 50-59.
Chicago
Langer, Thomas, Rosamaria Limuti, Concezione Tommasino, Niels V Regenmortel, Els L Duval, Pietro Caironi, and Manu L Malbrain et al. 2018. "Intravenous fluid therapy for hospitalized and critically ill children: rationale, available drugs and possible side effects". Anestezjologia Intensywna Terapia: 50-59.
Harvard
Langer, T., Limuti, R., Tommasino, C., Regenmortel, N., Duval, E., Caironi, P., Malbrain, M., and Pesenti, A. (2018). Intravenous fluid therapy for hospitalized and critically ill children: rationale, available drugs and possible side effects. Anestezjologia Intensywna Terapia, pp.50-59.
MLA
Langer, Thomas et al. "Intravenous fluid therapy for hospitalized and critically ill children: rationale, available drugs and possible side effects." Anestezjologia Intensywna Terapia, 2018, pp. 50-59.
Vancouver
Langer T, Limuti R, Tommasino C, Regenmortel N, Duval E, Caironi P et al. Intravenous fluid therapy for hospitalized and critically ill children: rationale, available drugs and possible side effects. Anestezjologia Intensywna Terapia. 2018:50-59.
